COMPARISON OF THE CLINICAL EFFICACY OF 5 IU AND 10 IU OF OXYTOCIN IN DECREASING POSTPARTUM BLOOD LOSS IN WARRI, DELTA STATE, NIGERIA.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202203814663421

Enrollment

150

Registered

2022-03-24

Start date

2020-05-20

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Pregnancy and Childbirth

Interventions

LOW DOSE ARM

STANDARD DOSE ARM

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Provide consent Term pregnancy Live fetus Singleton pregnancy Cephalic presenting fetus Parity less than 5

Exclusion criteria

Exclusion criteria: History of atonic postpartum haemorrhage Uterine fibroids Grand multiparity Previous caesarean section Multiple gestations Placenta praevia Use of anticoagulants or tocolytics Chorioamnionitis Any known uterine malformation History of coagulopathy.

Design outcomes

Primary

Measure	Time frame
Amount of postpartum blood loss	—

Secondary

Measure	Time frame
PPH greater than 500mls;PPH greater than 1000mls;Use of additional uterotonic;Need for blood transfusion;Adverse effects	—

Countries

Nigeria

Contacts

Public ContactOKWUCHUKWU ONYEOWUZONI

OBGYN Senior Registrar

OKWUWUZONI@GMAIL.COM+2347039739700

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026